Collaboration will combine Rosa's PhysioPD™ modeling & simulation capabilities with Biopontis' innovative asset sourcing and financial structure to improve early drug development productivity
Rosa & Co. LLC, a drug development advisory firm with expertise in drug-disease modeling and simulation, today announced the appointment of Mike Reed as Vice President.
The Model Qualification Method is a rigorous, systematic analysis of model relevance, uncertainty, variability, and consistency with data to ensure drug discovery/development models are "fit for purpose".
Dr. Rebecca Baillie, will present a webinar in Rosa's monthly public webinar series "How to build a PhysioPD model" on June 20, 2011 at 1:00 pm EDT (GMT -5:00).
Alliance combines innovative exploratory study design, leading in silico drug development capabilities, and a global licensing network to increase the value of emerging company portfolios and address pipeline gaps for established drug manufacturers.
Diabetes PhysioPD model used to predict long-term clinical outcomes and select doses using only summary pharmacokinetic data from a competitor's short-term Phase I clinical trial.
You are invited to attend Dr. Goburru's webinar The "Learn & Apply" Paradigm in Drug Development on April 18, 2011 at 1:00 pm EST (GMT -5:00) (www.rosaandco.com/webinar). This talk will summarize the state of the art in applying drug-disease-trial modeling to decision-making processes in drug development.
In collaboration with its clients, Lithera, MediciNova, Pfizer, Vitalea, Rosa & Co will present six posters at the 2011 American College on Pharmacometrics in San Diego, CA on April 4, 2011. The posters describe the use of drug-disease modeling in pharmaceutical development.
Rosa & Co. LLC, announce the appointment of Sharan A. Pagano, Vice President, Scientific Alliances, responsible for worldwide sales and account development, and the opening of Rosa's new Boston, MA-area office.
In collaboration with Vitalea Science, Inc., Rosa & Co will present the first clinical study of UDCA pharmacokinetics in neonates at the 2011 American Society for Clinical Pharmacology and Therapeutics in Dallas, TX entitled "Compartmental Analysis of Urosodiol PK in Neonates using AMS " at 8:00 am on March 4, 2011.
Satisfied Users & 
Approved Press Releases
